PatrickMDillonMD

Clinical Trials

• Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13

  Completed

  Phase 3

• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15

  Active, not recruiting

  Phase 3

• Study of Dovitinib (TKI258) in Adenoid Cystic Carcinoma Start of enrollment: 2012 Mar 01

  Completed

  Phase 2

• Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer Start of enrollment: 2012 Jul 01

  Terminated

  Phase 1

• A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer. Start of enrollment: 2013 Feb 26

  Completed

  Phase 2

• Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer Start of enrollment: 2013 Feb 01

  Completed

  Phase 2

• Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) Start of enrollment: 2017 Feb 02

  Terminated

  Phase 2

• Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer Start of enrollment: 2017 Sep 25

  Terminated

  Phase 1

• A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy Start of enrollment: 2019 Jan 29

  Completed

  Phase 1

• Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones Start of enrollment: 2020 Aug 04

  Active, not recruiting

  Phase 2

• Join now to see all